Financials
Financial year 2025
Dr. Bieke Lambert, Nucleaire Geneeskunde from Gent, company number BE0643684674, closed financial year 2025 with a result of € 427,661 after tax. For that financial year Dr. Bieke Lambert, Nucleaire Geneeskunde recorded a gross margin of € 579,436 and equity of € 929,368. Compared with financial year 2024, the result moved from € 405,461 to € 427,661. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 31, 2026.
€ 929,368
▲ 32% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 427,661
▲ 5% vs 2024
Profit after tax over the fiscal year.
€ 40,538
▼ 64% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 199,931 paid out
47 % of the profit went to the shareholders, the rest stayed in the company.
Debts at end 2025
€ 120,556
▲ 48% vs 2024
€ 20,451 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 27,611
▲ 11% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 412,655 | € 469,283 | € 574,254 | € 579,436 | ▲ 1% |
| Profit after taxes | € 285,803 | € 316,227 | € 405,461 | € 427,661 | ▲ 5% |
| Equity | € 874,634 | € 590,612 | € 701,638 | € 929,368 | ▲ 32% |
| Total debts | € 170,262 | € 187,529 | € 228,243 | € 148,191 | ▼ 35% |
| Cash | € 434,528 | € 212,076 | € 113,591 | € 40,538 | ▼ 64% |
| Land & buildings | € 437,003 | € 413,041 | € 399,636 | € 385,765 | ▼ 3% |
| Retained profit | € 856,084 | € 572,062 | € 683,088 | € 910,818 | ▲ 33% |
| Dividend | € 40,000 | € 600,249 | € 294,435 | € 199,931 | ▼ 32% |
| Bank debt | € 167,310 | € 124,458 | € 81,317 | € 120,556 | ▲ 48% |
| Balance sheet total | € 1,044,897 | € 778,141 | € 929,881 | € 1,077,559 | ▲ 16% |
Key figures of Dr. Bieke Lambert, Nucleaire Geneeskunde, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to Dr. Bieke Lambert, Nucleaire Geneeskunde?
What happened at Dr. Bieke Lambert, Nucleaire Geneeskunde in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 427,661 (▲ 5% vs 2024). Source: NBB ↗
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 285,803 profit in 2022 to € 427,661 profit in 2025.
Paid € 445,676 in corporate taxes since 2022.
Best year ever: 2025, with € 427,661 profit.
Paid out € 1.1 million in dividends to the owners in total.
Management
Behind Dr. Bieke Lambert, Nucleaire Geneeskunde is Bieke Lambert.
Directors
According to the 2025 annual accounts
Bieke Lambert
Manager
Establishments
Establishment units
Physical locations of this company
Oranjeboomstraat 27
9030 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0643.684.674
- VAT number
- BE 0643.684.674
- Registered office
- Oranjeboomstraat 27, 9030 Gent
- Names & denominations
- Dr. Bieke Lambert, Nucleaire Geneeskunde
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 November 2015
- Peppol
- Active · Active since 24 Nov 2025
- Activities · NACE
Activiteiten van medisch specialisten